Biologics Anika Completes Enrollment in Second Pivotal Phase III Trial of CINGAL for the Treatment of Knee Pain Associated with Osteoarthritis byJosh SandbergOctober 26, 2017
Extremities Anika Announces Publication of Phase III Data Demonstrating the Efficacy and Safety of CINGAL® byJosh SandbergMay 23, 2017
Top Stories Anika Announces European Commercial Launch of CINGAL for the Treatment of Pain Associated with Osteoarthritis byJosh SandbergJune 2, 2016
Extremities Anika Therapeutics Announces Canadian Launch of CINGAL for the Treatment of Pain Associated with Osteoarthritis of the Knee byJosh SandbergMay 20, 2016
Extremities Anika Therapeutics Wins CE Mark Approval for Cingal® for the Treatment of Pain Associated with Osteoarthritis of the Knee byJosh SandbergMarch 29, 2016
Hospitals Anika Therapeutics Announces Decision to Proceed with CINGAL® Premarket Review Through FDA’s Center for Drug Evaluation and Research byJosh SandbergDecember 9, 2015
Hospitals Anika Therapeutics Announces Health Canada Approval of CINGAL® for the Treatment of Pain Associated with Osteoarthritis of the Knee byJosh SandbergNovember 3, 2015
Extremities Top Stories Anika Therapeutics Announces Positive Results from Follow-up Study Evaluating Safety of a Repeat Injection of CINGAL for Treatment of Osteoarthritis of the Knee byJosh SandbergJuly 14, 2015
